Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "NovoCure"


9 mentions found


Cisco Systems — The networking technology stock added nearly 2% on the heels of a Citi upgrade to buy from neutral. The firm's earnings came in at $1.88 per share, versus the $1.58 expected by a LSEG analyst poll. Revenue was $15.38 billion versus the $14.41 billion consensus estimate. United also announced a $1.5 billion share buyback, its first since before the pandemic. J.B Hunt Transport Services — Shares jumped more than 7% after the company's third-quarter results topped expectations.
Persons: Novocure, Morgan Stanley —, accidently, J.B, Hunt, LSEG, — CNBC's Sean Conlon, Alex Harring, Sarah Min, Michelle Fox, Hakyung Kim Organizations: Cisco Systems, Citi, U.S . Food, Drug Administration, Revenue, United Airlines, United, Hunt, Locations: U.S
United Airlines – The stock soared 11% after the airline posted an earnings and revenue beat for the third quarter and guided for a strong fourth quarter. In addition, United said it is starting a $1.5 billion share buyback, its first since before the Covid pandemic. The firm posted earnings of $1.88 per share, higher than the $1.58 expected by a LSEG analyst poll. J.B Hunt Transport Services – Shares added 3.4% after the company posted a top and bottom line beat. J.B. Hunt posted $1.49 earnings per share on $3.07 billion of revenue in the third quarter.
Persons: United, Morgan Stanley, Novocure, J.B, Hunt, LSEG, Aspen Aerogels, FactSet, Prologis, Hamid Moghadam, , Alex Harring, Hakyung Kim, Samantha Subin, Pia Singh, Michelle Fox Organizations: Food and Drug Administration, United Airlines, Revenue, Cisco Systems, Citi, Food, ASML, J.B Hunt, Aspen, of Energy, U.S . Bancorp, General Motors, Lithium Americas Corp Locations: Dutch, U.S
A hotter-than-expected consumer price index on Tuesday sent stocks reeling, with the Dow posting its biggest drop in a year. Stocks bounced back over the next two days, helped by a softer retail sales report , only to slump again on Friday's hot producer price index for January. As we said this week, we're not overly concerned with the hotter-than-expected inflationary readings. Earnings season picks back up for the Club next week, with four holdings set to report quarterly results. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Persons: Wall, Stocks, we're, Palo, Fortinet, BCH's Bausch, Management doesn't, Dana, Bausch, Dr Pepper, Diana Shipping, Jim Cramer's, Jim Cramer, Jim, Jensen Huang, Walid Berrazeg Organizations: Dow Jones Industrial, Nasdaq, Dow, Federal Reserve, Club, Palo Alto, Palo, billings, Nvidia, Amazon, Microsoft, Bausch Health, Coterra Energy, Management, NYSE, Walmart, Axsome Therapeutics, Barclays Bank, Armstrong World Industries, Ceragon Networks, Tri Pointe Homes, Dana Incorporated, DigitalBridge, Oil States International, Systems, Allegion, CenterPoint Energy, Equitrans Midstream Corporation, Expeditors International of Washington, Alto Networks, SolarEdge Technologies, Enovix Corporation, Caesars Entertainment, Diamondback Energy, Toll, Ternium S.A, Celanese Corp, Chesapeake Energy, CVR Energy, Reserve, Vertiv Holdings Co, Properties Trust, Devices, HSBC Holdings plc, HSBC, Lomb, Sinclair Corporation, Pagaya Technologies, Gibraltar Industries, Garmin, NVIDIA, Rivian Automotive, Sunnova Energy International, Bros, Apache, Oil, Suncor Energy, Co, FNF, Sciences, Coeur D'Alene Mines, Trip.com, Joby Aviation, Resources, Alamos, Jackson, Nutrien, NTR, Pan, Sm Energy Company, Health, Newmont, Nikola Corporation, Cheniere Energy, Fiverr, Natural Resources, Point Credit, Lantheus Holdings, Builders, Grab Holdings, NICE, Dominion Energy, Harmony Biosciences Holdings, Teck Resources Limited, Intellia Therapeutics, Energy, Booking Holdings, Intuit, Semiconductor, Nation Entertainment, Vale S.A, Rocket Companies, Warner Bros ., AerCap Holdings, Natural Holdings, Calumet Specialty Products Partners, Frontier Communications, Jim Cramer's Charitable, CNBC, Lightrocket, Getty Locations: billings, Palo Alto, China, Xifaxan, Tri Pointe, Avista, Gibraltar, Coeur D'Alene, Pan American, Teck, Vale
Some stocks on Wall Street have been hit hard throughout the summer. CNBC scanned FactSet data to screen for the Russell 1000's hardest-hit stocks from Memorial Day through Wednesday's 4:30 p.m. Hawaiian Electric has gained notoriety in recent weeks after wildfires ravaged the historic town of Lahaina, Hawaii. HE 3M mountain Hawaiian Electric stock from Memorial Day. The stock has suffered as a result, with a decline of more than 66% between Memorial Day and Wednesday.
Persons: Russell, haven't, FactSet Organizations: Nasdaq, Dow Jones, CNBC, Electric, AMC, Hawaiian, Pharmaceuticals Locations: Lahaina , Hawaii
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: I've given up on Plug Power, too many disappointments and too many strikes'Mad Money' host Jim Cramer weighs in on stocks including: Plug Power, Nuscale Power, Lyondell, Novocure, Eaton, Reality Income, Owens Corning and Symbotic.
Persons: Jim Cramer, Owens Corning Locations: Novocure, Eaton, Symbotic
Cramer's Lightning Round: Stay away from Novocure
  + stars: | 2023-06-08 | by ( Julie Coleman | ) www.cnbc.com   time to read: +1 min
Stock Chart Icon Stock chart icon Plug Power's year-to-date stock performance. Stock Chart Icon Stock chart icon Nuscale Power's year-to-date stock performance. Stock Chart Icon Stock chart icon LyondellBasell's year-to-date stock performance. Stock Chart Icon Stock chart icon Novocure's year-to-date stock performance. Stock Chart Icon Stock chart icon Eaton's year-to-date stock performance.
Persons: they've, Nuscale, Eaton, Owens, Owens Corning Locations: Eaton
Check out the companies making headlines in premarket trading. GameStop — The meme stock added 2.4% premarket ahead of quarterly results on Wednesday. Petrobras — The Brazilian oil giant rose 2% in premarket trading after Morgan Stanley upgraded the stock to overweight from equal weight. NovoCure — The oncology company added 3.2% before the opening bell. Yext — The online marketing firm soared more than 17% in premarket trading on better-than-expected quarterly results.
Persons: Morgan Stanley, Coinbase, Wood, NovoCure, Yext, CNBC's Hakyung Kim, Jesse Pound, Yun Li Organizations: Netflix, JPMorgan, GameStop, FactSet, Petrobras —, SEC, of Clinical Locations: Krakow, Poland, premarket
June 6 (Reuters) - Novocure Ltd's <NVCR.O> experimental device to treat a type of lung cancer helped in extending overall survival among patients in a late-stage study, but concerns around its commercial success sent the medical device maker's shares down more than 34% on Tuesday. The device, used with certain chemotherapies and immunotherapies, helps in creating electric fields that disrupt cancer cell growth. Data from the study shows that the device, along with a class of immunotherapies know as immune checkpoint inhibitors (ICI), extended survival by about eight months, compared to patients treated with ICI alone. Lung cancer is the most common cause of cancer-related death worldwide, and NSCLC accounts for about 85% of all lung cancers, the company said. Reporting by Khushi Mandowara in Bengaluru; Editing by Nivedita Bhattacharjee, Shinjini Ganguli and Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
Persons: Emily Bodnar, Jefferies, Michael Yee, Novocure, Khushi, Nivedita Bhattacharjee, Shinjini, Maju Samuel Organizations: ICI, Wainwright, U.S . Food, Drug Administration, Thomson Locations: United States, U.S, Bengaluru
Wells Fargo expects upcoming results from Novocure's LUNAR trial to be a catalyst for the stock. Novocure shares were gaining 3.5% on the back of the Wells Fargo upgrade, which lifted the stock's rating to overweight from equal weight. Analyst Larry Biegelsen also set a new price target of $104 per share, which represents 33% upside from Monday's closing price of $78.38. The LUNAR trial studied the efficacy of combining tumor treating fields, which target tumors with electrical frequencies, with more traditional therapies, including immunotherapies, to treat non-small cell lung cancer. NVCR YTD mountain Novocure stock could yield as much as 33% upside ahead of cancer treatment study data, Wells Fargo says.
Total: 9